Oksikodon: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
WanaraLima (bicara | kontrib)
Artikel baru tentang topik farmasi yang masih memerlukan tambahan dan pengembangan. Artikel ini merupakan terjemahan wikipedia bahasa Inggris masih perlu ditinjau ulang juga disesuaikan dengan padanan bahasa Indonesia
 
(6 revisi perantara oleh 4 pengguna tidak ditampilkan)
Baris 1:
{{Infobox drug|image2=Oxycodone structure.png|routes_of_administration=[[Oral administration|By mouth]], [[sublingual administration|sublingual]], [[intramuscular injection|intramuscular]], [[intravenous injection|intravenous]], [[intranasal administration|intranasal]], [[subcutaneous injection|subcutaneous]], [[transdermal administration|transdermal]], [[rectal administration|rectal]], [[epidural administration|epidural]]<ref name="Kalso">{{cite journal |author = Kalso E |title = Oxycodone |journal = Journal of Pain and Symptom Management |volume = 29 |issue = 5S |pages = S47–S56 |year = 2005 |pmid = 15907646 |doi = 10.1016/j.jpainsymman.2005.01.010|doi-access = free }}</ref>|duration_of_action=By mouth (IR): 3–6 hrs<ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><br />By mouth (CR): 10–12 hrs<ref name="sunshine1996">{{cite journal |first1=Abraham |last1=Sunshine |first2=Nancy Z. |last2=Olson |first3=Ariel |last3=Colon |first4=Juana |last4=Rivera |first5=Robert F. |last5=Kaiko |first6=Ronald D. |last6=Fitzmartin |first7=Robert F. |last7=Reder |first8=Paul D. |last8=Goldenheim |title=Analgesic Efficacy of Controlled-Release Oxycodone in Postoperative Pain |journal=Journal of Clinical Pharmacology |date=July 1996 |volume=36 |issue=7 |pages=595–603 |doi=10.1002/j.1552-4604.1996.tb04223.x |pmid=8844441 |quote=Treatment with CR oxycodone was safe and effective in this study, and its characteristics will be beneficial in the treatment of pain.}}</ref>|dependency_liability=High<ref>{{cite book |last1=Bonewit-West |first1=Kathy |last2=Hunt |first2=Sue A. |last3=Applegate |first3=Edith |title=Today's Medical Assistant: Clinical and Administrative Procedures |date=2012 |page=571 |publisher=Elsevier Health Sciences |isbn=9781455701506 |url=https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571 |language=en |access-date=2020-08-05 |archive-date=2020-07-28 |archive-url=https://web.archive.org/web/20200728034412/https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571 |url-status=live }}</ref>|legal_status=<!-- For countries not listed above -->|bioavailability=By mouth: 60–87%<ref name = MSR>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=8 April 2014 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref><ref name="ElliottSmith2016" >{{cite book |author1=Jennifer A. Elliott |author2=Howard S. Smith |title=Handbook of Acute Pain Management |url=https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82 |date=19 April 2016 |publisher=CRC Press |isbn=978-1-4665-9635-1 |pages=82– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417032426/https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82 |url-status=live }}</ref>|protein_bound=45%<ref name = MSR>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=8 April 2014 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref>|metabolism=[[Liver]]: mainly [[CYP3A]], and, to a much lesser extent, [[CYP2D6]] (~5%);<ref name = MSR>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=8 April 2014 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref> 95% metabolized (i.e., 5% excreted unchanged)<ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref>|metabolites=• [[Noroxycodone]] (25%) <ref name=Medscape>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=4 January 2019 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref><ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><br />• [[Noroxymorphone]] (15%, free and [[Conjugation (biochemistry)|conjugated]])<ref name=Medscape>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=4 January 2019 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref><ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><br />• [[Oxymorphone]] (11%, conjugated)<ref name=Medscape>{{cite web |title=Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more |work=Medscape Reference |publisher=WebMD |accessdate=4 January 2019 |url=http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |archive-date=13 April 2014 |archive-url=https://web.archive.org/web/20140413145108/http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall |url-status=live }}</ref><ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><br />• Others (e.g., minor metabolites)<ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref>|elimination_half-life=By mouth (IR): 2–3 hrs (same {{abbrlink|t<sub>1/2</sub>|biological half-life}} for all {{abbrlink|ROAs|routes of administration}})<ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><ref name="ElliottSmith2016" >{{cite book |author1=Jennifer A. Elliott |author2=Howard S. Smith |title=Handbook of Acute Pain Management |url=https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82 |date=19 April 2016 |publisher=CRC Press |isbn=978-1-4665-9635-1 |pages=82– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417032426/https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82 |url-status=live }}</ref><br />By mouth (CR): 4.5 hrs<ref name="McPhersonPincus2016" >{{cite book |author1=Richard A. McPherson |author2=Matthew R. Pincus |title=Henry's Clinical Diagnosis and Management by Laboratory Methods |url=https://books.google.com/books?id=xAzhCwAAQBAJ&pg=PA336 |date=31 March 2016 |publisher=Elsevier Health Sciences |isbn=978-0-323-41315-2 |pages=336–}}</ref>|melting_point=219|melting_high=|boiling_point=}}
 
'''OksikodoOksikodon''' adalah [[obat]] golongan opioid yang digunakan untuk mengatasi keluhan [[nyeri]] derajat sedang hingga derajat berat. <ref name="AHFS2018">{{Cite web|title=Oxycodone Monograph for Professionals |url=https://www.drugs.com/monograph/oxycodone.html |website=Drugs.com |publisher=AHFS |archive-date=28 December 2018 |archive-url=https://web.archive.org/web/20181228174726/https://www.drugs.com/monograph/oxycodone.html |url-status=live |access-date=28 December 2018}}</ref> Sediaan obat oksikodon yang diminum, memiliki sediaan yang beragam ada sediaan yang menggunakan formulasi pelepasan segera dan pelepasan terkontrol . <ref name="AHFS2018">{{cite web |title=Oxycodone Monograph for Professionals |url=https://www.drugs.com/monograph/oxycodone.html |website=Drugs.com |publisher=AHFS |accessdate=28 December 2018 |archive-date=28 December 2018 |archive-url=https://web.archive.org/web/20181228174726/https://www.drugs.com/monograph/oxycodone.html |url-status=live }}</ref> Waktu onset dari obat oksikodon yang berefek pada pereda nyeri memiliki waktu 15 menit dan efek durasinya berlangsung hingga enam jam ini untuk sediaan yang menggunakan formulasi pelepasan segera. <ref name="AHFS2018">{{cite web |title=Oxycodone Monograph for Professionals |url=https://www.drugs.com/monograph/oxycodone.html |website=Drugs.com |publisher=AHFS |accessdate=28 December 2018 |archive-date=28 December 2018 |archive-url=https://web.archive.org/web/20181228174726/https://www.drugs.com/monograph/oxycodone.html |url-status=live }}</ref> Pada negara Inggris, obat oksikodon memiliki sediaan injeksi . <ref name="BNF74">{{Cite book|date=2017|title=British national formulary : BNF 74|publisher=British Medical Association|isbn=978-0857112989|edition=74|page=442}}</ref> Sediaan obat oksikodon tersedia dengan kombinasi obat pereda nyeri lainnya seperti [[parasetamol]] (asetaminofen), ibuprofen, nalokson, dan aspirin . <ref name="AHFS2018">{{cite web |title=Oxycodone Monograph for Professionals |url=https://www.drugs.com/monograph/oxycodone.html |website=Drugs.com |publisher=AHFS |accessdate=28 December 2018 |archive-date=28 December 2018 |archive-url=https://web.archive.org/web/20181228174726/https://www.drugs.com/monograph/oxycodone.html |url-status=live }}</ref>
 
== Referensi ==
[[Kategori:FarmasiObat yang dikembangkan oleh Pfizer]]
[[Kategori:ObatEter katekol]]
[[Kategori:4,5-Epoksimorfinan]]
[[Kategori:Euforian]]
[[Kategori:Opioid semisintetik]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
[[Kategori:Agonis reseptor mu-opioid]]